ARCHIVES

In Brief: NCI Names Rice To Head Frederick Center; NIAID Appoints Killen DAIDS Director

This article is from The Cancer Letter archive.

Vol. 20 No. 16 | April 22, 1994

Download PDF Visit The Full Archive

Related Articles

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

NCI Bypass Budget For FY99 Proposes Expansion of Cancer Clinical Trials System

December 5, 1997

RFP Suggestions For Immunodiagnosis Research Offered

October 22, 1976

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007

Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories”

October 24, 2014

NCI Community Intervention Trial Reports

March 10, 1995